Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis, with a ...
The initial report of a patient with visceral scleroderma without skin involvement was published in 1954, [1] and in 1962, the term "progressive systemic sclerosis sine scleroderma" was coined.